メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
岡山大学 ホーム
English
日本語
岡山大学でコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
設備
活動
プレス/メディア
受賞
Scopus著者プロファイル
大西 康博
助教
,
医歯薬学域
医学部
h-index
176
被引用数
8
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2000 …
2026
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(30)
類似のプロファイル
(6)
フィンガープリント
Yasuhiro Onishiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Chronic Kidney Disease
100%
Glomerular Filtration Rate
87%
Retrospective Study
61%
Cohort Analysis
55%
Triacylglycerol
55%
Disease Exacerbation
44%
Angiotensin II
38%
Observational Study
33%
Urinary System
32%
Diabetic Nephropathy
32%
Proteinuria
30%
Hazard Ratio
29%
Health Status
27%
Aortic Aneurysm
27%
Virus Gene
27%
Liver Failure
27%
Atherosclerosis
27%
CD40 Ligand
27%
Cooperation
27%
Liver Tissue
27%
Mental Health
27%
Immunoglobulin A Nephropathy
27%
Nonalcoholic Fatty Liver
27%
Chronic Hepatitis C
27%
Renal Biopsy
27%
Hepatitis B Virus
27%
Hepatocellular Carcinoma
27%
Lifestyle Intervention
27%
Olmesartan
27%
Lansoprazole
27%
Nephropathy
27%
Abdominal Aortic Aneurysm
27%
Microalbuminuria
27%
Angiotensin Converting Enzyme 2
27%
Hematoma
27%
Rapidly Progressive Glomerulonephritis
27%
Microscopic Polyangiitis
27%
Takayasu's Arteritis
27%
Apheresis
27%
Familial Hypercholesterolemia
27%
Plasmapheresis
27%
End Stage Renal Disease
21%
Log Rank Test
20%
Kidney Function
16%
Prednisolone
16%
Synapsin I
13%
Quality of Life
13%
Proportional Hazards Model
13%
Diseases
12%
Hepatitis C Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
59%
Chronic Hepatitis C
55%
Mouse
35%
Combination Therapy
33%
Health Status
27%
Liver Failure
27%
Alpha Interferon
27%
Olmesartan
27%
Abdominal Aortic Aneurysm
27%
Streptozotocin
27%
Liver Cell Carcinoma
27%
CD40 Ligand
27%
Amino Acid
27%
Ribavirin
27%
Interferon
27%
Hepatitis B Virus
27%
Aortic Aneurysm
27%
Human Albumin
27%
Antivirus Agent
27%
Immunoglobulin A Nephropathy
27%
Beta Interferon
27%
Angiotensin II
27%
Cohort Study
27%
Nonalcoholic Fatty Liver
27%
Atherosclerosis
27%
Pemafibrate
27%
Hemodialysis
27%
Hypertriglyceridemia
27%
Retrospective Study
27%
Dotinurad
27%
Aortic Arch Syndrome
27%
Albumin Receptor
23%
End Stage Renal Disease
18%
Gastrointestinal Symptom
16%
Prednisolone
16%
Disease Exacerbation
13%
Angiotensin
13%
Synapsin I
13%
Hepatitis C Virus
11%
Triacylglycerol
11%
Biological Product
11%
Immunosuppressive Agent
11%
Renin
9%
Antihypertensive Agent
9%
Dyslipidemia
8%
Virus DNA
7%
Liver Carcinogenesis
7%
Adverse Event
7%
Apolipoprotein C3
7%
Creatinine
7%
Keyphrases
Triglycerides Variability
55%
Minimum Difference
51%
Liver Tissue
27%
Type 2 Diabetic Mellitus
27%
Virus Gene
27%
Soluble CD40L
27%
Specific Health Checkup
27%
Lysosome Function
27%
Chronic Hepatitis C
27%
High-risk Subjects
27%
Hepatitis C
27%
Hepatitis B Virus
27%
Action Dynamics
27%
Lectin Array
27%
Urinary Diagnostics
27%
Medical Cooperation
27%
Vascular Senescence
27%
Hepatocellular Carcinoma Progression
27%
Rectus Sheath Hematoma
27%
Fasting Triglycerides
27%
Takayasu Arteritis
27%
Health Checkup
27%
Proteinuria
27%
Japan
27%
Dotinurad
27%
Childbirth
27%
Renal Disease
27%
LDL Adsorption
20%
Rapid Decliners
18%
OAS2
18%
Urine Dipstick
18%
Albumin Receptors
17%
Hepatocellular Carcinoma
16%
Gastrointestinal Symptom Rating Scale
16%
Prednisolone
16%
During Pregnancy
16%
Amaranthus Caudatus
15%
Erythrina Cristagalli Lectin
13%
Narcissus Pseudonarcissus
13%
ApoC-III
11%
Hepatitis B Virus DNA
11%
Hepatocarcinogenesis
11%
Limited Medical Resources
9%
Small Communities
9%
Municipal Employees
9%
Small Cities
9%
Viral Genotype
9%
Viral Decay
9%
TNFSF13B
9%
TNFSF13
9%
